A Phase 1 Study of LY2523355 in Patients with Acute Leukemia.

Trial Profile

A Phase 1 Study of LY2523355 in Patients with Acute Leukemia.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 22 Nov 2012

At a glance

  • Drugs Litronesib (Primary)
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Chronic myeloid leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Aug 2012 Actual end date Feb 2011 added as reported by ClinicalTrials.gov.
    • 01 Aug 2012 Last checked against ClinicalTrials.gov record.
    • 19 Nov 2011 Additional lead trial investigator identified as reported by M.D. Anderson Cancer Center record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top